US Stock MarketDetailed Quotes

CYCC Cyclacel Pharmaceuticals

Watchlist

0.4400
-0.0021-0.48%

Trading Nov 6 10:24 ET

946.50KMarket Cap-28P/E (TTM)

Cyclacel Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

-40.97%6M

-75.53%2.8M

-81.59%3.38M

-74.93%5.94M

-65.04%10.16M

-61.42%11.44M

-49.82%18.35M

-41.06%23.71M

-Cash and cash equivalents

-40.97%6M

-75.53%2.8M

-81.59%3.38M

-74.93%5.94M

-65.04%10.16M

-61.42%11.44M

-49.82%18.35M

-41.06%23.71M

Receivables

-52.21%1.41M

-75.92%1.67M

-33.95%3.73M

-20.30%3.22M

47.20%2.94M

46.75%6.94M

31.04%5.64M

60.66%4.04M

-Taxes receivable

-52.21%1.41M

-75.92%1.67M

-33.95%3.73M

-20.30%3.22M

47.20%2.94M

46.75%6.94M

31.04%5.64M

60.66%4.04M

Other current assets

-86.28%300K

-38.66%365K

-19.95%341K

1,047.06%1.95M

2,667.09%2.19M

-61.34%595K

439.24%426K

51.79%170K

Total current assets

-49.61%7.71M

-74.52%4.84M

-69.51%7.44M

-60.19%11.11M

-52.32%15.29M

-48.13%18.97M

-40.38%24.41M

-35.64%27.92M

Non current assets

Net PPE

-52.70%70K

-49.41%86K

-41.38%102K

-34.21%125K

-29.19%148K

136.11%170K

85.11%174K

65.22%190K

-Gross PPE

-52.70%70K

-49.41%86K

-6.28%522K

-34.21%125K

-29.19%148K

136.11%170K

22.42%557K

65.22%190K

-Accumulated depreciation

----

-9.66%-420K

----

-6.09%-383K

----

Non current prepaid assets

-58.70%413K

-57.34%1.24M

-63.67%1.26M

-56.82%1.26M

-67.32%1M

-2.15%2.92M

65.00%3.47M

93.24%2.92M

Total non current assets

-57.93%483K

-56.90%1.33M

-62.60%1.36M

-55.44%1.38M

-64.88%1.15M

1.11%3.09M

65.86%3.64M

91.26%3.11M

Total assets

-50.19%8.19M

-72.05%6.17M

-68.61%8.81M

-59.71%12.5M

-53.48%16.44M

-44.33%22.06M

-34.97%28.05M

-31.06%31.02M

Liabilities

Current liabilities

Payables

118.58%4.74M

107.25%5.2M

38.34%3.54M

59.82%1.57M

-1.63%2.17M

-11.96%2.51M

20.97%2.56M

-35.12%983K

-accounts payable

118.58%4.74M

107.25%5.2M

38.34%3.54M

59.82%1.57M

-1.63%2.17M

-11.96%2.51M

20.97%2.56M

-35.12%983K

Current accrued expenses

-52.80%2.05M

-38.04%2.85M

7.45%4.24M

94.53%6.22M

91.91%4.34M

42.34%4.61M

55.09%3.94M

63.92%3.2M

Other current liabilities

68.80%395K

32.74%296K

-62.23%380K

106.98%356K

-58.06%234K

88.98%223K

33.60%1.01M

37.60%172K

Current liabilities

6.52%7.19M

13.79%8.35M

8.65%8.16M

87.18%8.15M

34.22%6.75M

18.28%7.34M

38.76%7.51M

21.22%4.35M

Non current liabilities

Long term debt and capital lease obligation

-92.42%5K

-73.75%21K

-65.09%37K

-51.40%52K

-41.59%66K

433.33%80K

253.33%106K

143.18%107K

-Long term capital lease obligation

-92.42%5K

-73.75%21K

-65.09%37K

-51.40%52K

-41.59%66K

433.33%80K

253.33%106K

143.18%107K

Total non current liabilities

-92.42%5K

-73.75%21K

-65.09%37K

-51.40%52K

-41.59%66K

433.33%80K

253.33%106K

143.18%107K

Total liabilities

5.56%7.19M

12.85%8.37M

7.63%8.2M

83.86%8.2M

32.55%6.81M

19.28%7.42M

39.94%7.62M

22.70%4.46M

Shareholders'equity

Share capital

-99.96%2K

-99.98%1K

-99.73%12K

40,836.36%4.5M

44,930.00%4.5M

44,850.00%4.5M

44,930.00%4.5M

-common stock

-99.96%2K

-99.98%1K

-99.73%12K

40,836.36%4.5M

44,930.00%4.5M

44,850.00%4.5M

44,930.00%4.5M

-Preferred stock

--0

Retained earnings

-4.09%-434.49M

-4.68%-431.23M

-5.56%-428.28M

-6.09%-423.01M

-6.04%-417.41M

-5.88%-411.96M

-5.51%-405.73M

-5.02%-398.74M

Paid-in capital

3.01%436.4M

1.56%429.92M

1.61%429.8M

1.40%428.46M

-0.35%423.63M

0.01%423.32M

0.00%422.98M

0.18%422.54M

Gains losses not affecting retained earnings

16.59%-915K

26.63%-898K

31.00%-908K

33.10%-1.17M

14.03%-1.1M

-48.72%-1.22M

-75.94%-1.32M

-131.87%-1.75M

Total stockholders'equity

-89.63%999K

-115.07%-2.21M

-97.03%607K

-83.82%4.3M

-68.12%9.63M

-56.17%14.64M

-45.79%20.43M

-35.79%26.56M

Total equity

-89.63%999K

-115.07%-2.21M

-97.03%607K

-83.82%4.3M

-68.12%9.63M

-56.17%14.64M

-45.79%20.43M

-35.79%26.56M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	-40.97%6M	-75.53%2.8M	-81.59%3.38M	-81.59%3.38M	-74.93%5.94M	-65.04%10.16M	-61.42%11.44M	-49.82%18.35M	-49.82%18.35M	-41.06%23.71M
-Cash and cash equivalents	-40.97%6M	-75.53%2.8M	-81.59%3.38M	-81.59%3.38M	-74.93%5.94M	-65.04%10.16M	-61.42%11.44M	-49.82%18.35M	-49.82%18.35M	-41.06%23.71M
Receivables	-52.21%1.41M	-75.92%1.67M	-33.95%3.73M	-33.95%3.73M	-20.30%3.22M	47.20%2.94M	46.75%6.94M	31.04%5.64M	31.04%5.64M	60.66%4.04M
-Taxes receivable	-52.21%1.41M	-75.92%1.67M	-33.95%3.73M	-33.95%3.73M	-20.30%3.22M	47.20%2.94M	46.75%6.94M	31.04%5.64M	31.04%5.64M	60.66%4.04M
Other current assets	-86.28%300K	-38.66%365K	-19.95%341K	-19.95%341K	1,047.06%1.95M	2,667.09%2.19M	-61.34%595K	439.24%426K	439.24%426K	51.79%170K
Total current assets	-49.61%7.71M	-74.52%4.84M	-69.51%7.44M	-69.51%7.44M	-60.19%11.11M	-52.32%15.29M	-48.13%18.97M	-40.38%24.41M	-40.38%24.41M	-35.64%27.92M
Non current assets
Net PPE	-52.70%70K	-49.41%86K	-41.38%102K	-41.38%102K	-34.21%125K	-29.19%148K	136.11%170K	85.11%174K	85.11%174K	65.22%190K
-Gross PPE	-52.70%70K	-49.41%86K	-6.28%522K	-6.28%522K	-34.21%125K	-29.19%148K	136.11%170K	22.42%557K	22.42%557K	65.22%190K
-Accumulated depreciation	----	----	-9.66%-420K	-9.66%-420K	----	----	----	-6.09%-383K	-6.09%-383K	----
Non current prepaid assets	-58.70%413K	-57.34%1.24M	-63.67%1.26M	-63.67%1.26M	-56.82%1.26M	-67.32%1M	-2.15%2.92M	65.00%3.47M	65.00%3.47M	93.24%2.92M
Total non current assets	-57.93%483K	-56.90%1.33M	-62.60%1.36M	-62.60%1.36M	-55.44%1.38M	-64.88%1.15M	1.11%3.09M	65.86%3.64M	65.86%3.64M	91.26%3.11M
Total assets	-50.19%8.19M	-72.05%6.17M	-68.61%8.81M	-68.61%8.81M	-59.71%12.5M	-53.48%16.44M	-44.33%22.06M	-34.97%28.05M	-34.97%28.05M	-31.06%31.02M
Liabilities
Current liabilities
Payables	118.58%4.74M	107.25%5.2M	38.34%3.54M	38.34%3.54M	59.82%1.57M	-1.63%2.17M	-11.96%2.51M	20.97%2.56M	20.97%2.56M	-35.12%983K
-accounts payable	118.58%4.74M	107.25%5.2M	38.34%3.54M	38.34%3.54M	59.82%1.57M	-1.63%2.17M	-11.96%2.51M	20.97%2.56M	20.97%2.56M	-35.12%983K
Current accrued expenses	-52.80%2.05M	-38.04%2.85M	7.45%4.24M	7.45%4.24M	94.53%6.22M	91.91%4.34M	42.34%4.61M	55.09%3.94M	55.09%3.94M	63.92%3.2M
Other current liabilities	68.80%395K	32.74%296K	-62.23%380K	-62.23%380K	106.98%356K	-58.06%234K	88.98%223K	33.60%1.01M	33.60%1.01M	37.60%172K
Current liabilities	6.52%7.19M	13.79%8.35M	8.65%8.16M	8.65%8.16M	87.18%8.15M	34.22%6.75M	18.28%7.34M	38.76%7.51M	38.76%7.51M	21.22%4.35M
Non current liabilities
Long term debt and capital lease obligation	-92.42%5K	-73.75%21K	-65.09%37K	-65.09%37K	-51.40%52K	-41.59%66K	433.33%80K	253.33%106K	253.33%106K	143.18%107K
-Long term capital lease obligation	-92.42%5K	-73.75%21K	-65.09%37K	-65.09%37K	-51.40%52K	-41.59%66K	433.33%80K	253.33%106K	253.33%106K	143.18%107K
Total non current liabilities	-92.42%5K	-73.75%21K	-65.09%37K	-65.09%37K	-51.40%52K	-41.59%66K	433.33%80K	253.33%106K	253.33%106K	143.18%107K
Total liabilities	5.56%7.19M	12.85%8.37M	7.63%8.2M	7.63%8.2M	83.86%8.2M	32.55%6.81M	19.28%7.42M	39.94%7.62M	39.94%7.62M	22.70%4.46M
Shareholders'equity
Share capital	-99.96%2K	-99.98%1K	-99.98%1K	-99.98%1K	-99.73%12K	40,836.36%4.5M	44,930.00%4.5M	44,850.00%4.5M	44,850.00%4.5M	44,930.00%4.5M
-common stock	-99.96%2K	-99.98%1K	-99.98%1K	-99.98%1K	-99.73%12K	40,836.36%4.5M	44,930.00%4.5M	44,850.00%4.5M	44,850.00%4.5M	44,930.00%4.5M
-Preferred stock	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Retained earnings	-4.09%-434.49M	-4.68%-431.23M	-5.56%-428.28M	-5.56%-428.28M	-6.09%-423.01M	-6.04%-417.41M	-5.88%-411.96M	-5.51%-405.73M	-5.51%-405.73M	-5.02%-398.74M
Paid-in capital	3.01%436.4M	1.56%429.92M	1.61%429.8M	1.61%429.8M	1.40%428.46M	-0.35%423.63M	0.01%423.32M	0.00%422.98M	0.00%422.98M	0.18%422.54M
Gains losses not affecting retained earnings	16.59%-915K	26.63%-898K	31.00%-908K	31.00%-908K	33.10%-1.17M	14.03%-1.1M	-48.72%-1.22M	-75.94%-1.32M	-75.94%-1.32M	-131.87%-1.75M
Total stockholders'equity	-89.63%999K	-115.07%-2.21M	-97.03%607K	-97.03%607K	-83.82%4.3M	-68.12%9.63M	-56.17%14.64M	-45.79%20.43M	-45.79%20.43M	-35.79%26.56M
Total equity	-89.63%999K	-115.07%-2.21M	-97.03%607K	-97.03%607K	-83.82%4.3M	-68.12%9.63M	-56.17%14.64M	-45.79%20.43M	-45.79%20.43M	-35.79%26.56M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data